Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bill Ackman Buys Air Products & Chemicals, Inc. (APD), Sells General Growth Properties Inc (GGP), Bets Big on The Procter & Gamble Company (PG)

Investor Bill Ackman runs Pershing Square, a hedge fund with about $11 billion under management. Ackman’s general strategy is a combination of value investing and activism — Pershing Square buys up large stakes in undervalued companies and works with the firm’s management to improve the underlying business.

In the second quarter, Pershing Square purchased a large stake in Air Products & Chemicals, Inc. (NYSE:APD), sold some of its General Growth Properties Inc (NYSE:GGP) , and bought nearly $2 billion worth of calls on The Procter & Gamble Company (NYSE:PG).

Ackman’s next war could be with Air Products

In the second quarter, Ackman acquired over 10 million shares of Air Products & Chemicals, Inc. (NYSE:APD) for his primary fund Pershing Square. He also bought shares of the company in a special purpose vehicle, raising additional funds to push for change.

Air Products & Chemicals, Inc. (NYSE:APD)’s management caught on to Ackman’s activities, and adopted a poison pill back in July. If any single shareholder were to acquire more than 10% of the company, existing shareholders would be granted the right to purchase more shares — thereby diluting Ackman’s stake. Consequently, Ackman stopped just short of the 10% threshold.

Pershing Square has yet to make its plan for Air Products & Chemicals, Inc. (NYSE:APD) known. But if the management disagrees with Ackman, he will likely make his ideas public, as frequently turns to the media.

Pershing Square was forced to fight a proxy contest with Canadian Pacific — a contest it ultimately won. Pershing Square’s new management team has done a phenomenal job of turning around the company, and shares are up more than 44% in the last year.


It’s possible that something similar could happen with Air Products & Chemicals, Inc. (NYSE:APD). The company hasn’t been a particularly good investment in recent years — since 2010, shares are up 2%, and that includes the recent rally prompted by Ackman’s involvement.

If Ackman begins agitating for a change, the company’s suffering shareholders could accept his ideas.

Ackman pairs back General Growth

Pershing Square’s investment in General Growth Properties Inc (NYSE:GGP) has been impressive, to say the least. During the depths of the financial crisis, Pershing Square brought up a large stake in the company at about $0.71 per share.

Those shares are now worth about $20, not to mention the value of the spin-off, Howard Hughes.

But now, after nearly 5 years, Pershing Square may be starting to exit. The firm sold about 9% of its stake in the second quarter.

Last year, Pershing Square and General Growth Properties Inc (NYSE:GGP) had a disagreement. Ackman wanted General Growth to sell itself to rival Simon Property Group, while General Growth Properties Inc (NYSE:GGP)’s management wished to remain independent.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.